Anesiva and its co-promotion partner Sagent Pharmaceuticals, Inc. are working in tandem to educate caregivers about the importance of addressing peripheral venous access pain in children, and to ensure Zingo availability through hospital pharmacies. Anesiva's seasoned team of 15 hospital-based regional account managers with an average of 14 years' industry experience, led by two directors who have a combined 30 years' experience, will drive the launch of this product in the United States. Sagent has assigned 15 field representatives, all of whom have an average of more than 18 years' hospital selling experience and whose national account representatives have an average of 25 years of hospital sales experience.
Zingo is currently manufactured with established, approved processes. Anesiva continues to pursue Zingo manufacturing scale-up in order to reduce cost of goods and meet anticipated increasing market demand.
Anesiva intends to grow a global brand for Zingo through geographically
based license and distribution agreements with companies that have
expertise in hospital-based markets in their territories, and has already
entered into agreements for several major markets. Sigma Tau SpA will
market Zingo in most major European markets; Medical Futures, Inc. is
responsible for commercializing Zingo in Canada; and Green Vision Company
will commercialize Zingo in several countries in the Middle East. Planning
for local re
|SOURCE Anesiva, Inc.|
Copyright©2008 PR Newswire.
All rights reserved